Literature DB >> 20573638

Calculating sample size in trials using historical controls.

Song Zhang1, Jing Cao, Chul Ahn.   

Abstract

BACKGROUND: Makuch and Simon [Sample size considerations for non-randomised comparative studies. J Chronic Dis 1980; 33: 175-81.] developed a sample size formula for historical control trials. When assessing power, they assumed the true control treatment effect to be equal to the observed effect from the historical control group. Many researchers have pointed out that the Makuch-Simon approach does not preserve the nominal power and type I error when considering the uncertainty in the true historical control treatment effect.
PURPOSE: To develop a sample size formula that properly accounts for the underlying randomness in the observations from the historical control group.
METHODS: We reveal the extremely skewed nature in the distributions of power and type I error, obtained over all the random realizations of the historical control data. The skewness motivates us to derive a sample size formula that controls the percentiles, instead of the means, of the power and type I error.
RESULTS: A closed-form sample size formula is developed to control arbitrary percentiles of power and type I error for historical control trials. A simulation study further demonstrates that this approach preserves the operational characteristics in a more realistic scenario where the population variances are unknown and replaced by sample variances. LIMITATIONS: The closed-form sample size formula is derived for continuous outcomes. The formula is more complicated for binary or survival time outcomes.
CONCLUSIONS: We have derived a closed-form sample size formula that controls the percentiles instead of means of power and type I error in historical control trials, which have extremely skewed distributions over all the possible realizations of historical control data.

Entities:  

Mesh:

Year:  2010        PMID: 20573638      PMCID: PMC3085081          DOI: 10.1177/1740774510373629

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  13 in total

1.  Group sequential designs for phase II trials with historical controls.

Authors:  M N Chang; J J Shuster; J L Kepner
Journal:  Control Clin Trials       Date:  1999-08

2.  Uniform power method for sample size calculation in historical control studies with binary response.

Authors:  J J Lee; C Tseng
Journal:  Control Clin Trials       Date:  2001-08

3.  The use of historical controls and concurrent controls to assess the effects of sulphonamides, 1936-1945.

Authors:  Irvine Loudon
Journal:  J R Soc Med       Date:  2008-03       Impact factor: 5.344

4.  Successful outcomes of EMR-L with 3D-EUS for rectal carcinoids compared with historical controls.

Authors:  Tsuyoshi Abe; Tadayoshi Kakemura; Sumio Fujinuma; Iruru Maetani
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

5.  Setting the bar in phase II trials: the use of historical data for determining "go/no go" decision for definitive phase III testing.

Authors:  Andrew J Vickers; Vennus Ballen; Howard I Scher
Journal:  Clin Cancer Res       Date:  2007-02-02       Impact factor: 12.531

6.  Sample size considerations for studies comparing survival curves using historical controls.

Authors:  D O Dixon; R Simon
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

7.  Sample size considerations for non-randomized comparative studies.

Authors:  R W Makuch; R M Simon
Journal:  J Chronic Dis       Date:  1980

8.  Results of 101 aneurysms treated with polyglycolic/polylactic acid microfilament nexus coils compared with historical controls treated with standard coils.

Authors:  W J van Rooij; A N de Gast; M Sluzewski
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-29       Impact factor: 3.825

9.  Analysis of 29 consecutive thoracoscopic repairs of congenital diaphragmatic hernia in neonates compared to historical controls.

Authors:  S David Cho; Sanjay Krishnaswami; Julie C Mckee; Garret Zallen; Mark L Silen; David W Bliss
Journal:  J Pediatr Surg       Date:  2009-01       Impact factor: 2.545

10.  Mild therapeutic hypothermia shortens intensive care unit stay of survivors after out-of-hospital cardiac arrest compared to historical controls.

Authors:  Christian Storm; Ingo Steffen; Joerg C Schefold; Anne Krueger; Michael Oppert; Achim Jörres; Dietrich Hasper
Journal:  Crit Care       Date:  2008-06-14       Impact factor: 9.097

View more
  6 in total

1.  Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design.

Authors:  R G Miller; D H Moore; D A Forshew; J S Katz; R J Barohn; M Valan; M B Bromberg; K L Goslin; M C Graves; L F McCluskey; A L McVey; T Mozaffar; J M Florence; A Pestronk; M Ross; E P Simpson; S H Appel
Journal:  Neurology       Date:  2011-08-03       Impact factor: 9.910

2.  Survival trial design and monitoring using historical controls.

Authors:  Jianrong Wu; Xiaoping Xiong
Journal:  Pharm Stat       Date:  2016-06-15       Impact factor: 1.894

3.  Sample size considerations for historical control studies with survival outcomes.

Authors:  Hong Zhu; Song Zhang; Chul Ahn
Journal:  J Biopharm Stat       Date:  2015-06-22       Impact factor: 1.051

Review 4.  A Review of Causal Inference for External Comparator Arm Studies.

Authors:  Gerd Rippin; Nicolás Ballarini; Héctor Sanz; Joan Largent; Chantal Quinten; Francesco Pignatti
Journal:  Drug Saf       Date:  2022-07-27       Impact factor: 5.228

5.  Creation and implementation of a historical controls database from randomized clinical trials.

Authors:  Jigar R Desai; Edward A Bowen; Mark M Danielson; Rajasekhar R Allam; Michael N Cantor
Journal:  J Am Med Inform Assoc       Date:  2013-02-28       Impact factor: 4.497

6.  Nasogastric or nasojejunal feeding in predicted severe acute pancreatitis: a meta-analysis.

Authors:  Yu-sui Chang; Hua-qun Fu; Yuan-mei Xiao; Ji-chun Liu
Journal:  Crit Care       Date:  2013-06-20       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.